期刊论文详细信息
Cancer Communications | |
Differentiation therapy: a promising strategy for cancer treatment | |
Quentin Liu1  Min Yan2  | |
[1] Institute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, P.R. China;State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China | |
关键词: Differentiation therapy; Cancer treatment; IkB kinase α; | |
DOI : 10.1186/s40880-015-0059-x | |
学科分类:肿瘤学 | |
来源: Springer | |
【 摘 要 】
Poor differentiation is an important hallmark of cancer cells, and differentiation therapy holds great promise for cancer treatment. The restoration of IkB kinase α (IKKα) leads to the differentiation of nasopharyngeal carcinoma cells with reduced tumorigenicity. The findings by Yan et al. validate the polycomb protein enhancer of zeste homologue 2 (EZH2) as a target for intervention.
【 授权许可】
CC BY
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO201904021165441ZK.pdf | 1039KB | download |